X

Nutraplus India Ltd. Stock Analysis

Small Cap
Evaluated by 246 users | BSE: 524764 | NSE: |
Pharmaceuticals & Drugs
Nutraplus Products India (NPIL) was incorporated as a private limited company in February 1990. The company's manufacturing unit was commissioned to make APIs and intermediates in 1995. Various products were made earlier. For a fine organic chemical manufacturing unit, the first 6 to 7 years...

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Capital Employed 8.73%17.88%17.31%12.51%12.56%1.86%9.46%-2.78%2.45%4.31%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 14.136.244.739.561.76577.691109140
Y-o-Y Gr. Rt.-155.8%23.7%-11.6%56.1%5.4%19.3%17.3%19.9%27.9%
Adjusted EPS (Rs.) 0.592.112.5922.45-0.762.55-2.120.030.39
Y-o-Y Gr. Rt.-257.6%22.8%-22.8%22.5%-131%NA-183.1%NA1200%
Book Value per Share (Rs.) 7.258.9911.2113.215.5916.3320.8619.7219.7220.37
Adjusted Net Profit 0.62.232.53.2-1.97.1-7.20.11.3
Net Op. Cash Flow (Rs. Cr.) -0.12.87.63.54-16.5-9.619.76.712.4
Debt to Cash Flow from Ops -97.493.381.976.27.93-2.44-7.53.3510.976.06
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Nutraplus India Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales 29%17.7%21.6%27.9%
Adjusted EPS -4.5%-30.8%-46.5%1200%
Book Value per Share 12.25.5-0.83.3
Share Price -3.8% -45.7% -41.7% -30.7%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19
Return on Equity (%) 8.6126.3626.5416.6117.13-5.5312.94-11.120.131.96
Operating Profit Margin (%) 14.8413.8814.1918.8516.634.9215.66-2.078.469.21
Net Profit Margin (%) 3.996.086.626.225.15-2.879.18-7.950.080.96
Debt to Equity 1.121.021.161.341.5611.240.981.091.08
Working Capital Days 195110140197164246314295243150
Cash Conversion Cycle 80322728384932564541
Entity Percentage Holding
Promoters 40.07%
Institutions 0.03%
Non-Institutions 59.91%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Nutraplus India's performance infers:

Nutraplus India earnings have declined by -30.8%, whereas share price has depreciated -45.7% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Nutraplus India share prices over the last 10 years. Here is what we found out:

Nutraplus India share price has depreciated -3.6% annually over the past ten years.

Nutraplus Products India (NPIL) was incorporated as a private limited company in February 1990. The company's manufacturing unit was commissioned to make APIs and intermediates in 1995. Various products were made earlier. For a fine organic chemical manufacturing unit, the first 6 to 7 years period was crucial in a sense that proficiency in handling certain unit processes were developed. Based on such expertise, higher value and profitable products then could be taken up. In spite of

Nutraplus Products India (NPIL) was incorporated as a private limited company in February 1990. The company's manufacturing unit was commissioned to make APIs and intermediates in 1995. Various products were made earlier. For a fine organic chemical manufacturing unit, the first 6 to 7 years period was crucial in a sense that proficiency in handling certain unit processes were developed. Based on such expertise, higher value and profitable products then could be taken up. In spite of liberalization of imports, reduction in import duties and indigenous competition, the company has withstood uncertainties.

The company intends to take up manufacture of an API and its intermediates by way of expansion of fixed assets. Up till now, the company adopted a stringy to carry out job working and also make selected products for a merchant exporter on fixed quantity and rate. The products made by the company hence, were exported by the merchant exporter. 

The registered office of the company is located at 7- A Vakil Villa, H F Society Road End, Jogeshwari E Mumbai, Maharashtra 400060.

Product of the company

  • N Bromo Succinimide 
  • N Methyl Nitro Guanidine
  • Chlorhexidine Gluconate  
  • 7- Chloro Quinaldine  
  • M Bromo Anisole
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback